Oxidative stress and apoptosis

Pathophysiology

Volumn 7, Issue 3, 2000, Pages 153-163

  Kannan, Krishnaswamy ^a   Jain, Sushil K ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis inducing factor; Apoptotic protease activating factor 1; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CASPASE; CYTOCHROME C; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; APOPTOSIS; AUTOIMMUNE DISEASE; BRAIN ISCHEMIA; CANCER; CELL SURVIVAL; CYTOSOL; DIABETES MELLITUS; HEART MUSCLE ISCHEMIA; HUMAN; MITOCHONDRION; MORPHOLOGY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033805442     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(00)00053-5     Document Type: Review

References (121)

1. Schwartzman R.A., Cidlowski L.A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev. 14:1993;133-151.
2. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
3. Kerr L.F.R., Winterford C.M., Harmon B.N. Apoptosis: its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
4. Duke R.C., Ojcius D.M., Young D.E. Cell suicide in health and disease. Sci. Am. 275:1996;80-87.
5. Kerr L.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
6. Editorial: Cell Death in Us and Others. Science 281 (1998) 1283.
7. Burtke T.M., Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today. 15:1994;7-10.
8. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA. 96:1999;10964-10967.
9. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
10. Zamzami N., Susin S.A., Marchetti P., Hirsch T., Gomez Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1996;1533-1544.
11. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1988;1309-1311.
12. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis; doubt no more. Biochim. Biophys. Acta. 1366:1998;151-165.
13. Y. Morel, Barouki. Repression of gene expression by oxidative stress, Biochem J (1999) 342: 481-496.
14. 2+-mediated endogenous endonuclease activation in apoptotic thymocytes. J. Immunol. 155:1995;5133-5139.
15. 2+ and their relationship to apoptosis and oncogenesis. FEBS. 325:1993;104-107.
16. Byczkowski J.Z., Gessner T. Biological role of superoxide ion radical. Int. J. Biochem. 20:1988;569-580.
17. Fridovich I. Superoxide radical: an endogenous toxicant. Ann. Rev. Pharmacol. Toxicol. 23:1983;239-257.
18. MeGowan A.J., Fernandes R.S., Samali A., Cotter T.G. Anti-oxidants and apoptosis. Biochem. Soc. Trans. 24:1996;229-267.
19. Hockenberry D.M. Bcl-2, a novel regulator of cell death. BioEssays. 17:1995;631-638.
20. Korsmeyer S.J., Yin X., Oltvai Z.N., Veis-Novack D.J., Linette G.P. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim. Biophys. Acta. 1271:1995;63-66.
21. Hockenbery D.M., Oltvai Z.N., Yin X.M., Millman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Immunol. Today. 18:(1993):1993;44-51.
22. Voehringer D.W. Bcl-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Rad. Biol. Med. 27:1999;945-950.
23. Kroemer G., Zamzami N., Susin S.A. Mitochondrial control of apoptosis. Immunol. Today. 18:1997;44-51.
24. Nagata S. Fas-mediated apoptosis. Adv. Exp. Med. Biol. 406:1996;119-124.
25. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
26. Schwandner R., Wiegmann K., Bernardo K., Kreder D., Kronke M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273:1998;5916-5922.
27. Kitson L., Raven T., Jiang Y.P., Goeddel D.V., Giles K.M., Pun K.T., Grinham C.J., Brown R., Farrow S.N. A death-domain-containing receptor that mediates apoptosis. Nature. 384:1996;372-375.
28. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
29. Schneider P., Thome M., Burns K., Bodmer L.L., Hofmann K., Kataoka T., Holler N., Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappa-B. Immunity. 7:1997;831-836.
30. Wertz I.E., Hanley M.R. Diverse molecular provocation of programmed cell death. Trends Biochem. Sci. 21:1996;359-364.
31. Lederman S., Cleary A.M., Yellin M.J., Frank D.M., Karpusas M., Thomas D.W., Chess L. The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated diffirentiation of B lymphocytes. Curr. Opin. Hematol. 3:1996;77-86.
32. Klaus G.G., Choi M.S., Lam E.W., Johnson-Leger C., Cliff J. CD40: a pivotal receptor in the determination of life/death decisions in B lymphocytes. Int. Rev. Immunol. 15:1997;5-31.
33. Du Y., Bales K.R., Dodel R.C., Hamilton-Byrd E., Horn L.W., Czilli D.L., Simmons L.K., Ni B., Paul S.M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 94:1997;11657-11662.
34. Gross A., McDonnell J.M., Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Develop. 13:1999;1899-1911.
35. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
36. Hampton M.B., Orrenius S. Redox regulation of apoptotic cell death in the immune system. Toxicol. Lett. 102-103:1998;355-358.
37. Alnemri E.S., Livingston D.J., Nicholson D.W., Salvesen G., Thomberry N.A., Wong W.W., Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
38. Martin S.L., Green D.R. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:1995;349-352.
39. Zhivotovsky B., Burgess D.H., Vanags D.M., Orrenius S. Involvement of proteolytic machinery in apoptosis. Biochem. Biophys. Res. Comm. 230:1997;481-488.
40. Casciola-Rosen L., Nicholson D.W., Chong T., Rowan K.R., Thornberry N.A., Miller D.X., Rosen A. Apopain/CPP32 cleaves proteins that are essential cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1996;1957-1964.
41. Zhivotovsky B., Gahm A., Ankarcrona M., Nicotera P., Orrenius S. Multiple proteases are involved in thymocyte apoptosis. Exp. Cell. Res. 221:1995;404-412.
42. Henkart P.A. ICE family proteases: mediators of all apoptotic cell death? Immunity. 4:1996;195-201.
43. Sies H. Oxidative Stress. 1985;Academic Press, London.
44. Sato N., Iwata S., Nakamura K., Hori T., Mori K., Yodoi J. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J. Immunol. 154:1995;3194-3203.
45. Kehrer L.P., Lund L.G. Cellular reducing equivalents and oxidative stress. Free Radic. Biol. Med. 17:1994;65-75.
46. Reed D.J., Savage M.K. Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status. Biochim. Biophys. Acta. 1271:1995;43-50.
47. Kowaltowski A., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. 26:1999;463-471.
48. Halliwell B, Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1989;Oxford University Press, Oxford.
49. Petit P.X., Susin S.A., Zamzami N., Mignotte B., Kroemer G. Mitochondria and programmed cell death: back to the future. FEBS Lett. 396:1996;7-13.
50. Marchetti P., Castedo M., Susin S.A., Zamzami N., Hirsch T., Macho A., Haeffner A., Hirsch F., Geuskens M., Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1996;1155-1160.
51. Castedo M., Macho A., Zamzami N., Hirsch T., Marchetti P., Uriel J., Kroemer G. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:1995;3277-3284.
52. Zamzami N., Hirsch T., Dallaporta B., Petit P.X., Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29:1997;185-193.
53. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.
54. Marzo I., Susin S.A., Petit P.X., Ravagnan L., Brenner C., Larochette N., Zamzami N., Kroemer G. Caspases disrupt mitochondrial membrane barrier function. FEBS Lett. 427:1998;198-202.
55. Scarlett L.L., Murphy M.P. Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition. FEBS Lett. 418:1997;282-286.
56. Yang J.C., Cortopassi G.A. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome C. Free Radic. Biol. Med. 24:(1998):1998;624-631.
57. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285.
58. Pennesi E. Superoxide relay Ras protein's oncogenic message. Science. 275:1997;1567-1568.
59. Ushio-Fukai M., Alexander R.W., Akers M., Griendling K.K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273:1998;15022-15029.
60. Bae Y.S., Kang S.W., Seo M.S., Bainers I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EW receptormediated tyrosine phosphorylation. J. Biol. Chem. 272:1997;217-221.
61. Babier B.M. Oxygen-dependent microbial killing by phagocytes. New Engl. J. Med. 298:1978;659-668.
62. Horton A.A., Fairhurst S. Lipid peroxidation and mechanisms of toxicity. CRC Crit. Rev. Toxicol. 18:1987;27-79.
63. Jaescheke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc. Soc. Exp. Biol. Med. 209:1995;104-111.
64. Reed D.J. Toxicity of oxygen. De Matteis F., Smith L.L. Molecular and Cellular Mechanisms of Toxicity. 1995;35-68 CRC Press, New York.
65. Sies H. Biochemistry of oxidant stress. Agrew. Chem. Int. Ed. 25:1986;1058-1071.
66. Kannan K., Jain S.K. Effect of high glucose on cellular proliferation and lipid peroxidation in cultured Vero cells. Horm. Metab. Res. 26:1994;322-325.
67. Jain S.K. The accumulation of Malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 25:1984;3391-3394.
68. Jain S.K. In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats. J Clin. Invest. 76:1985;281-286.
69. Jain S.K. The neonatal erythrocyte and its oxidative susceptibility. Semin. Hernatol. 26:1989;286-300.
70. Jain S.K. Evidence for membrane lipid peroxidation during the in vivo aging of human erytbrocytes. Biochim. Biophys. Acta. 937:1988;205-210.
71. Jain S.K., Kannan K., Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic. Biol. Med. 25:1998;1083-1088.
72. Reiter R.J., Guerrero J.M., Garcia J.J., Acuna-Castroviejo D. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann. N.Y.Acad. Sci. 854:1998;410-424.
73. Christen Y. Oxidative stress and Alzhieimer disease. Am. J. Clin. Nutr. 71:2000;621S-629S.
74. Kannan K., Holcombe R.F., Jain S.K., Chervenak R., Wolf R.E., Glass J. Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line. Mol. Cell Biochem. 205:2000;53-66.
75. Kappus H. Oxidative stress in chemical toxicity. Arch. Toxicol. 60:1987;144-149.
76. Mates J.M., Sanchez-Jimenez F.M. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell Biol. 32:2000;157-170.
77. Ambs S., Hussain S.P., Maarrogi A.J., Harris C.C. Cancer-prone oxyradical overload disease. IARC Sci. Publ. 150:1999;295-302.
78. Lee J.M., Bernstein A. Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev. 14:1995;149-161.
79. Cotter F.E. Antisense therapy of hematologic malignancies. Semin. Hematol. 36:1999;9-14.
80. Muller I., Niethammer D., Bruchelt G. Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity. Int. J. Mol. Med. 1:1998;491-494.
81. Romero-Alvira D., Roche E. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med. Hypotheses. 51:1998;169-173.
82. Bartz S.R., Emerman M. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J. Virol. 73:1999;1956-1963.
83. Guigliano O., Ceriello A. Oxidative stress and diabetic vascular complications. Diab. Care. 19:1996;257-267.
84. Ho E., Bray T.M. Antioxidants, NFkappaB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 222:1999;205-213.
85. Hamaoki R., Fujii J., Miyagawa J., Takahashi M., Kishimoto M., Moriwaki M., Yamamoto K., Kajimoto Y., Yamasaki Y., Hanafusa T., Matsuzawa Y., Taniguchi N. Overexpression of the aldose reductase gene induces apoptosis in pancreatic beta-cells by causing redox imbalance. J. Biochem. (Tokyo). 126:1999;41-47.
86. Kowluru R.A., Engerman R.L., Kern T.S. Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic. Res. 32:2000;67-74.
87. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., Hanafusa T., Matsuzawa Y., Yamasaki Y., Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes. 48:1999;2398-2406.
88. Du X., Stockklauser-Farber K., Rosen P. Generation of reactive oxygen intermediates, activation of NF-KB and induction of aoptosis in human endothelial cells by glucose: role of nitric oxide synthase. Free Radic. Biol. Med. 27:1999;752-763.
89. Carden D.L., Granger D.N. Pathophysiology of ischeamia-reperfusion injury. J. Pathol. 190:2000;255-266.
90. Semenza G.L. Cellular and molecular dissection of reperfusion injury: ROS within and without. Circ. Res. 86:2000;117-118.
91. WaJsh A.C., Michaud S.G., Malossi L.A., Lawrence D.A. Glutathione depletion in human T lymphocytes: analysis of activation-associated gene expression and the stress response. Toxicol. Appl. Pharmacol. 133:1995;249-261.
92. Crawford D.R., Abramova N.E., Davies K.J. Oxidative stress causes a general, calcium-dependent degradation of mitochondrial polynucleotides. Free Radic. Biol. Med. 25:1998;1106-1111.
93. Esteve J.M., Mompo J., Garcia J., Asuncion J.G.D., Sastre J., Asensi M., Boix J., Vina J.R., Pallardo F.V. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J. 13:1999;1055-1064.
94. Richter C. Reactive oxygen and DNA damage in mitochondria. Mutat. Res. 275:1992;249-255.
95. Wallace D.C. Mitochondrial diseases in man and disease. Science. 283:(1999):1999;1482-1487.
96. Vogt T.M., Welsh L., Stolz W., Kullmann E., Jung B., Landthaler N., McClelland M. RNA fingerprinting displays UVB-specific disruption of transcriptional control in human melanocytes. Cancer Res. 57:1997;3554-3561.
97. Williams G.T., Smith C.A. Molecular regulation of apoptosis: genetic controls on cell death. Cell. 74:1993;777-779.
98. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1448.
99. Chinnaiyan A.M., O'Rourke K., Lane B.R., Dixit V.M. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science. 275:1977;1122-1126.
100. Oren M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev. 11:1992;141-148.
101. 2+ requiring, cyclosporin-sensitive pathway. Biochem. Biophys. Res. Commun. 161:1989;619-625.
102. Gunter T.E., Pfeiffer D.R. Mechanisms by which initochondria transport calcium. Am. J. Physiol. 258:1990;C755-C786.
103. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., Walter R., Yaffee M. Oxidants in mitochondria: from physiology to disease. Biochim. Biophys. Acta. 1127:1995;67-74.
104. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:(8):1997;1481-1486.
105. Richter C., Schweizer M., Cossarizza A., Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett. 378:1996;107-110.
106. Oren M. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol. 5:1994;221-227.
107. Adams L.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1325.
108. Antonsson B., Conti E., Ciavatta A., Montessuit S., et al. Inhibition of Bax channel forming activity by Bcl-2. Science. 277:1997;370-372.
109. Yang E., Korsmeyer S.J. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood. 88:1996;386-401.
110. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
111. Soabo L., Zoratti M. The mitochondrial megachannel is the permeability transition pore. J. Bioenerg. Biomembr. 24:1992;111-117.
112. 2+ induced permeabilization of rat liver mitochondria. Biochem. J. 239:1986;19-29.
113. 2+. J. Biol. Chem. 268:1993;1011-1016.
114. Gutierrez P.L., Bachur N.R. Free radicals in quinone containing antitumor agents. The nature of the diaziquone (3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone) free radical. Biochim. Biophys. Acta. 758:1983;37-41.
115. Jain S.K., Shohet S.B. Calcium potentiates the peroxidation of erythrocyte membrane lipids. Biochim. Biophys. Acta. 642:1981;46-54.
116. Thomas D., Hanley M.R. Pharmacological tools for perturbing intracellular calcium storage. Methods Cell Biol. 40:1994;65-89.
117. Kuwana T., Smith J.J., Muzio M., Dixit V., Newmeyer D.D., Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome C. J. Biol. Chem. 26:1998;16589-16594.
118. Scaffidi C.S., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 APOA/Fas signaling pathways. EMBO J. 17:1998;1675-1687.
119. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
120. Kuida K., Hayder T.F., Ktian C.Y., Gu Y., Taya C., Karasuyama H., Su M.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
121. Cecconi F., Alvarez Bolado G., Meyer B.I., Roth K.A., Gruss P. Apaf 1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 94:1998;727-737.